Anti-Psoriasis Drug Itolizumab is Approved in India to Treat COVID-19 Following Human Trial with 30 Subjects
Dr. Shuvomoy Banerjee, Neucrad Health Desk, July 18, 2020 Biocon, a Bangalore-based biopharmaceutical company, has received approval for its plaque psoriasis drug Itolizumab (Brand name- Alzumab) f…
